Journal
FUTURE MEDICINAL CHEMISTRY
Volume 5, Issue 6, Pages 705-714Publisher
FUTURE SCI LTD
DOI: 10.4155/FMC.13.47
Keywords
-
Categories
Funding
- Institute of Chemical and Engineering Sciences in Singapore
- National Science Foundation [CHE-0906179]
- NIU Inaugural Board of Trustees Professorship Award
- Chinese Academy of Sciences
- Direct For Mathematical & Physical Scien
- Division Of Chemistry [0906179] Funding Source: National Science Foundation
Ask authors/readers for more resources
Recently, boron compounds have attracted increasing attention both in academic laboratories and in the pharmaceutical industry. Boron, in particular the B-10 isotope, has the unique capability of absorbing a slow neutron to initiate a nuclear reaction with release of energetic particles such as alpha- and Li-particles, which is not observed in its carbon analogues. The nuclear capture reaction concept has been adopted in radiation therapy and used in boron neutron capture therapy (BNCT). BNCT is a potentially promising treatment for malignant brain tumors as well as other cancers, despite the limitation of a scarcity of neutron sources. There is the need in advanced research centers to construct high boron-containing composites as BNCT agents and develop more efficient drug carriers. This review discusses recent works on the development of boron-based therapeutic nanomaterials as BNCT agents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available